Dermavant Submits New Drug Application (NDA) to FDA for Tapinarof Cream for the Treatment of Adults…
Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, announced that it has submitted…
Read More...
Read More...
